After 4 months of using a GLP-1 microdose, the level of energy improved significantly, her flare-ups reduced to once a month, and we are now tapering down the use of medication
AOD-9604 vs Other Research Peptides AOD-9604 sits in a different mechanistic category than most of the compounds its commonly compared against its the only one on this list that acts directly on fat tissue without touching appetite signaling or the growth hormone axis
Real-World Analysis of Glucagon Like Peptide-1 (GLP-1) Agonist Obesity Treatment Year-Two Clinical and Cost Outcomes (July 2024)
Reaching the goal weight is not the end of treatment
Ghosh says the injectable GLP-1s out there remain far superior for blood sugar control and weight loss because of the way theyre metabolized
Alteogen said Monday that its proprietary ultra-long-acting platform, built with protein engineering, is designed to extend dosing to once a month, beyond its existing NexP platform that targets once-weekly administration